NASDAQ:DRNA
Delisted

Dicerna Pharmaceuticals Stock Price (Quote)

$38.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.22 $38.22 Friday, 27th May 2022 DRNA stock ended at $38.22. During the day the stock fluctuated 0% from a day low at $38.22 to a day high of $38.22.
90 days $38.22 $38.22
52 weeks $19.06 $40.14

Historical Dicerna Pharmaceuticals prices

Date Open High Low Close Volume
Apr 27, 2021 $29.22 $30.49 $29.17 $30.28 681 566
Apr 26, 2021 $28.79 $29.58 $28.18 $29.37 469 953
Apr 23, 2021 $28.90 $29.26 $28.66 $28.68 473 422
Apr 22, 2021 $29.30 $29.80 $28.55 $28.86 1 218 918
Apr 21, 2021 $30.16 $30.42 $28.84 $29.38 864 914
Apr 20, 2021 $29.02 $30.92 $28.90 $30.46 698 892
Apr 19, 2021 $29.11 $29.76 $28.74 $29.09 397 958
Apr 16, 2021 $29.57 $30.39 $28.84 $28.96 761 983
Apr 15, 2021 $28.20 $29.00 $27.70 $28.53 788 954
Apr 14, 2021 $27.06 $28.33 $27.02 $27.83 508 009
Apr 13, 2021 $26.50 $27.33 $25.80 $26.83 680 720
Apr 12, 2021 $26.37 $26.43 $24.70 $26.18 748 561
Apr 09, 2021 $26.50 $26.63 $25.62 $26.09 536 996
Apr 08, 2021 $26.30 $27.03 $25.75 $26.42 717 735
Apr 07, 2021 $26.00 $26.33 $25.38 $25.75 423 954
Apr 06, 2021 $26.68 $27.17 $26.04 $26.14 408 261
Apr 05, 2021 $26.27 $27.24 $26.13 $27.16 682 059
Apr 01, 2021 $25.78 $26.58 $25.37 $25.76 403 756
Mar 31, 2021 $24.25 $25.92 $24.25 $25.57 687 068
Mar 30, 2021 $23.13 $24.78 $22.60 $24.12 1 461 505
Mar 29, 2021 $24.07 $24.44 $22.82 $23.25 473 832
Mar 26, 2021 $24.04 $24.31 $23.14 $24.09 526 852
Mar 25, 2021 $22.50 $24.11 $21.79 $23.97 1 012 866
Mar 24, 2021 $24.40 $24.70 $22.76 $22.91 762 372
Mar 23, 2021 $26.18 $26.33 $24.21 $24.33 686 457
Click to get the best stock tips daily for free!

About Dicerna Pharmaceuticals

Dicerna Pharmaceuticals Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding the liver enzyme glycolate oxidase; and other rare inherit... DRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT